In patients with gastrointestinal cancers treated with fluoropyrimidine-based chemotherapy agents, better overall survival at 1 year offsets a small increase in their risk of CV events, new data ...

Clinicians need to address maternal health at all stages, with some seeing a possible new role for GLP-1 drugs.

There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.

The ABCVM wanted to certify cardiologists outside of ABIM, but the recent denial doesn’t mean their efforts have stopped.

The dynamic field of advanced heart failure, and helping these patients live comfortably, has inspired this fellow.

CHICAGO, IL—An investigational agent given by subcutaneous injection can drastically reduce levels of lipoprotein (a), with ...

Though ischemic outcomes numerically favored the Amulet, confirmation in future studies is needed, experts say.

For every 100,000 runners who complete the full 42.2 km distance, there will be one cardiac arrest, new data show.

The transition from adolescence can bring decreased physical activity, a worse diet, and little focus on overall CV health.

The study is the latest showing that it doesn’t matter how exercise gets done in a week, as long as it gets done.

The drug was approved last year for patients with hypertension currently not controlled on other BP-lowering agents.

David Ferreira talks to C. Michael Gibson about the latest data showing patients don't need to fast ahead of cardiac ...